fingolimod hydrochloride has been researched along with Adenopathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bettelli, E; Buckner, JH; Duhen, R; Eken, A; Fry, M; Kita, M; Oukka, M; Singh, AK | 1 |
1 other study(ies) available for fingolimod hydrochloride and Adenopathy
Article | Year |
---|---|
S1P
Topics: Animals; Autoimmunity; Case-Control Studies; Disease Susceptibility; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Gene Deletion; Humans; Inflammation; Lymphadenopathy; Lymphoid Tissue; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Organ Specificity; Phenotype; Receptors, Lysosphingolipid; T-Lymphocytes, Regulatory; Th17 Cells; Transcription, Genetic | 2017 |